1. Wellstein A Giaccone G Atkins MB Sausville Chapter 66:  Cytotoxic Drugs in Goodman & Gilman's:  The Pharmacological Basis of Therapeutics, 13e, Brunton LL Hilal-Dandan R Knollmann BC, eds) 2018.

2. Sausville EA Longo DL Chapter 103e Principles of Cancer Treatment, in Harrison's Online   (Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo,  J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 19th edition, The McGraw-Hill Companies, Inc. 2015.

3. Chu E  Cancer Chemotherapy Chapter 54 in Basic & Clinical Pharmacology, 14 e (Katzung BG The McGraw-Hill Companies, 2018 (on-line edition)

4. Tew KD Chapter 17:  Alkylating Agents  in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

5. Collins JM Cancer Pharmacology Chapter 29 in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

6. Saif MW Chu E Chapter 19 Antimetabolites in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

7. Wellstein A Giaccone G Atkins MB Sausville Chapter 67:  Pathway-Targeted Therapies:  Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules in Goodman & Gilman's:  The Pharmacological Basis of Therapeutics, 13e, Brunton LL Hilal-Dandan R Knollmann BC, eds) 2018.

8. Chau CH Figg WD Chabner BA Antimitiotic Drugs Chapter 11 in:  Cancer Chemotherapy, Immunotherapy and Biotherapy Principles and Practice Chabner BA Longo DL, eds 6e Wolters Kluwer 2019.

9. Hoimes CJ Chapter 24: Antimicrotubule Agents in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 11e Wolters Kluwer Health 2018.

10. Berlin J Gemcitabine and capecitabine needs further scrutiny. https://www.youtube.com/watch?v=HZbOn8F2hb8

11. Wakelee H The taxane of choice for managing NSCLE is nab-paclitaxel. ImedexCME; Published August 15, 2013; https://www.youtube.com/watch?v=RbLUH7GiNlc

12.  Wax AG Study of Nob-Paclitaxel with Pembrolizumab  for Patients with HR⁺/HER2^- Breast Cancer; Dana-Farber Cancer Instutute; Published April 4, 2019. https://www.youtube.com/watch?v=0FAhxQM28js

This Web-based pharmacology teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.